RB
Richmond Brothers Portfolio holdings
AUM
$153M
This Quarter Return
+32.86%
1 Year Return
+15.91%
3 Year Return
+117.95%
5 Year Return
–
10 Year Return
–
AUM
$61.8M
AUM Growth
+$61.8M
(+4.2%)
Cap. Flow
-$10.9M
Cap. Flow
% of AUM
-17.57%
Top 10 Holdings %
Top 10 Hldgs %
92.82%
Holding
24
New
2
Increased
2
Reduced
18
Closed
2
Top Buys
| 1 |
Invesco Global Listed Private Equity ETF
PSP
|
$556K |
| 2 |
ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
|
$87.2K |
| 3 |
Heron Therapeutics
HRTX
|
$49.2K |
| 4 |
IRD
Opus Genetics, Inc. Common Stock
IRD
|
$5.79K |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
$3.99M |
| 2 |
Apple
AAPL
|
$2.14M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
$1.35M |
| 4 |
MiMedx Group
MDXG
|
$1.11M |
| 5 |
Guggenheim Strategic Opportunities Fund
GOF
|
$955K |
Sector Composition
| 1 | Healthcare | 23.72% |
| 2 | Technology | 16.01% |
| 3 | Financials | 10.06% |
| 4 | Consumer Discretionary | 1.54% |
| 5 | Communication Services | 1.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Invesco QQQ Trust
QQQ
$364B
| $18.9M | 30.62% |
51,163
-10,806
| -17% | -$3.99M |
|
|
2
MiMedx Group
MDXG
$1.05B
| $10.5M | 16.98% |
1,586,500
-168,627
| -10% | -$1.11M |
|
|
3
Apple
AAPL
$3.45T
| $7.45M | 12.06% |
38,389
-11,050
| -22% | -$2.14M |
|
|
4
Berkshire Hathaway Class B
BRK.B
$1.09T
| $6.21M | 10.06% |
18,221
-3,958
| -18% | -$1.35M |
|
|
5
Guggenheim Strategic Opportunities Fund
GOF
$2.62B
| $4.11M | 6.66% |
258,660
-60,036
| -19% | -$955K |
|
6
Microsoft
MSFT
$3.77T
| $2.44M | 3.95% |
7,167
-644
| -8% | -$219K |
|
7
Rockwell Medical
RMTI
$58.9M
| $2.31M | 3.74% |
422,624
-33,314
| -7% | -$182K |
|
8
ARK Innovation ETF
ARKK
$7.45B
| $2.21M | 3.58% |
50,132
-8,422
| -14% | -$372K |
|
9
iShares Biotechnology ETF
IBB
$5.6B
| $1.7M | 2.76% |
13,410
-3,314
| -20% | -$421K |
|
|
IRD
10
Opus Genetics, Inc. Common Stock
IRD
$73.1M
| $1.48M | 2.4% |
341,860
+1,334
| +0.4% | +$5.79K |
|
11
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.53B
| $731K | 1.18% |
62,451
-4,281
| -6% | -$50.1K |
|
|
12
Invesco Global Listed Private Equity ETF
PSP
$332M
| $556K | 0.9% |
+52,889
| New | +$556K |
|
13
Amazon
AMZN
$2.44T
| $490K | 0.79% |
3,758
-128
| -3% | -$16.7K |
|
14
McDonald's
MCD
$224B
| $460K | 0.75% |
1,541
-88
| -5% | -$26.3K |
|
15
Alphabet (Google) Class C
GOOG
$2.58T
| $460K | 0.74% |
3,800
-120
| -3% | -$14.5K |
|
16
Air Industries Group
AIRI
$15.2M
| $454K | 0.74% |
127,890
-7,129
| -5% | -$25.3K |
|
17
iShares Core S&P 500 ETF
IVV
$662B
| $403K | 0.65% |
905
-10
| -1% | -$4.46K |
|
18
Verizon
VZ
$186B
| $266K | 0.43% |
7,153
-2,135
| -23% | -$79.4K |
|
19
Procter & Gamble
PG
$368B
| $243K | 0.39% |
1,602
-265
| -14% | -$40.2K |
|
20
Johnson & Johnson
JNJ
$427B
| $224K | 0.36% |
1,349
-404
| -23% | -$66.9K |
|
|
ONCT
21
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $100K | 0.16% |
291,032
+252,670
| +659% | +$87.2K |
|
|
22
Heron Therapeutics
HRTX
$207M
| $49.2K | 0.08% |
+42,405
| New | +$49.2K |
|
23
Invesco S&P 500 Low Volatility ETF
SPLV
$8B
| – | – |
-4,143
| Closed | -$259K |
|
24
AT&T
T
$209B
| – | – |
-11,300
| Closed | -$218K |
|